European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment
Autor: | Samreen Ahmed, Peter Vuylsteke, Alvydas Česas, Gustav J. Ullenhag, Piotr J. Wysocki, Ruth Vera Garcia, Stefan Rauh, Heikki Minn, Jeanine M.L. Roodhart, Markus Borner, Jeroen W.G. Derksen, Anneli Elme, Graham W. Warren, Nikolaos Tsoukalas, Deirdre O'Mahony, Anne M. May, Miriam Koopman, Karin Jordan, Siniša Radulović |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Male 0301 basic medicine Cessation Cancer Research medicine.medical_specialty Tobacco use medicine.medical_treatment Treatment outcome 03 medical and health sciences 0302 clinical medicine Neoplasms Internal medicine medicine Humans Practice Patterns Physicians' Aged Cancer Oncologists Physician-Patient Relations Cancer och onkologi Practice patterns business.industry Palliative Care Smoking Treatment Setting Middle Aged medicine.disease Cancer treatment Europe 030104 developmental biology Oncology 030220 oncology & carcinogenesis Cancer and Oncology Palliative intent Smoking cessation Supportive care Female Smoking Cessation business |
Popis: | Background:Smoking cessation after a cancer diagnosis is associated with improved overall survival. Few studies have reported oncologists' cessation practice patterns, but differences between the curative and palliative settings have not been described. We aimed to study the oncologist's perceptions on patients' tobacco use, current practices and barriers to providing smoking cessation support, while distinguishing between treatment with curative (C) and palliative (P) intent. Methods:In 2019, an online 34-item survey was sent to approximately 6235 oncologists from 16 European countries. Responses were descriptively reported and compared by treatment setting. Results:Responses from 544 oncologists were included. Oncologists appeared to favour addressing tobacco in the curative setting more than in the palliative setting. Oncologists believe that continued smoking impacts treatment outcomes (C: 94%, P: 74%) and that cessation support should be standard cancer care (C: 95%, P: 63%). Most routinely assess tobacco use (C: 93%, P: 78%) and advise patients to stop using tobacco (C: 88%, P: 54%), but only 24% (P)-39% (C) routinely discuss medication options, and only 18% (P)-31% (C) provide cessation support. Hesitation to remove a pleasurable habit (C: 13%, P: 43%) and disbelieve on smoking affecting outcomes (C: 3%, P: 14%) were disparate barriers between the curative and palliative settings (p < 0.001), but dominant barriers of time, resources, education and patient resistance were similar between settings. Conclusion:Oncologists appear to favour addressing tobacco use more in the curative setting; however, they discuss medication options and/or provide cessation support in a minority of cases. All patients who report current smoking should have access to evidence-based smoking cessation support, also patients treated with palliative intent given their increasing survival. |
Databáze: | OpenAIRE |
Externí odkaz: |